日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sirolimus modulates the erythroid differentiation of K562 cells by upregulating SHP1.

西罗莫司通过上调 SHP1 来调节 K562 细胞的红系分化

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06518-4
Yang Yuan, Tang Zengwei, Hu Qinglin, Yang Chen, Chen Miao, Jing Hongmei, Han Bing
细胞生物学
发表日期：2025
文献求助 收藏

Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study

西罗莫司与环孢素A治疗原发性获得性纯红细胞再生障碍性贫血患者的疗效比较：一项前瞻性队列研究

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00845-3
Yang, Yuan; Tang, Zengwei; Huang, Yuzhou; Hu, Qinglin; Wang, Shuqing; Ji, Jiang; Du, Yali; Yang, Chen; Chen, Miao; Hu, Shimin; Han, Bing
红细胞
细胞生物学
贫血
代谢
发表日期：2023
文献求助 收藏

Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients

更正：表观遗传失调介导的COL12A1上调预示着肝内胆管癌患者预后不良

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-023-01455-3
Tang, Zengwei; Yang, Yuan; Zhang, Qi; Liang, Tingbo
肿瘤
表观遗传
肿瘤免疫
胆管癌
COL
发表日期：2023
文献求助 收藏

Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2.

肠道菌群失衡通过调节色氨酸代谢和上调 SREBP2 促进肝癌的发生

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2203894119
Chen Wen, Wen Liang, Bao Yingying, Tang Zengwei, Zhao Jianhui, Zhang Xiaozhen, Wei Tao, Zhang Jian, Ma Tao, Zhang Qi, Zhi Xiao, Li Jin, Zhang Cheng, Ni Lei, Li Muchun, Liang Tingbo
代谢
肝癌
肠道菌群
发表日期：2022
文献求助 收藏

Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

更正：增强子去甲基化上调MCM2和NUP37表达，预示肝细胞癌患者预后不良

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-022-03766-0
Tang, Zengwei; Yang, Yuan; Chen, Wen; Li, Enliang; Liang, Tingbo
肿瘤
表观遗传
肿瘤免疫
MCM2
细胞生物学
发表日期：2022
文献求助 收藏

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement

靶向HGF/MET轴的癌症治疗：耐药性的挑战和改进的机会

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2020.00152
Huang, Xing; Li, Enliang; Shen, Hang; Wang, Xun; Tang, Tianyu; Zhang, Xiaozhen; Xu, Jian; Tang, Zengwei; Guo, Chengxiang; Bai, Xueli; Liang, Tingbo
HGF
肿瘤
MET
肿瘤免疫
发表日期：2020
文献求助 收藏

Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma

紫藤凝集素-唾液酸化粘蛋白1在人类胆管癌诊断价值及粘蛋白1预后作用的荟萃分析

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2018-021693
Tang, Zengwei; Yang, Yuan; Wang, Xiaolu; Meng, Wenbo; Li, Xun
肿瘤
胆管癌
肿瘤免疫
发表日期：2019
文献求助 收藏

Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: A systematic review and meta-analysis

术前胆管炎对肝门部胆管癌患者预后的影响：系统评价和荟萃分析

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000012025
Wang, Yudong; Fu, Wenkang; Tang, Zengwei; Meng, Wenbo; Zhou, Wence; Li, Xun
胆管癌
肿瘤免疫
肿瘤
发表日期：2018
文献求助 收藏

The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis

可切除性肝门部胆管癌患者预后相关临床病理因素：系统评价和荟萃分析

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000011999
Tang, Zengwei; Yang, Yuan; Zhao, Zhonghong; Wei, Kongyuan; Meng, Wenbo; Li, Xun
胆管癌
肿瘤免疫
肿瘤
发表日期：2018
文献求助 收藏